The balance sheet gives him room to move - Lal PathLabs is sitting on about Rs.1,400 crore of net cash and no debt, and can ...
Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and ...
BENGALURU (Reuters) - Dr. Lal PathLabs, India's biggest diagnostics firm by revenue, posted a higher profit for the third straight quarter on Thursday, due to more diagnostics and tests in the monsoon ...
BENGALURU, May 11 (Reuters) - India's Dr. Lal PathLabs Ltd (DLPA.NS), opens new tab on Thursday reported a sixth consecutive fall in quarterly profit as a continued slide in income from COVID-related ...
BENGALURU, Aug 7 (Reuters) - Dr. Lal PathLabs (DLPA.NS), opens new tab reported first-quarter profit above expectations on Wednesday on strong demand for its medical tests in smaller cities and towns ...
Dr. Om Manchanda, Managing Director at Dr. Lal PathLabs, is a summit seeker who has explored trails in Uttarakhand, Slovenia, Scotland, Italy, and Tanzania. Leading a healthcare giant in the country, ...
Mumbai-based Jashvik Capital has marked the first close of its maiden $350 Mn fund. The private equity (PE) firm announced the fund in July 2022 with plans to close the same by July 2023. With this ...
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...
Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. PrecisionCHD is a clinical blood test that can detect CHD at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results